Ultrasound-assisted drug-delivery method and system based on time reversal acoustics

• US 7,985,184 B2
• Filed: 04/23/2010
• Issued: 07/26/2011
• Est. Priority Date: 09/10/2005
• Status: Expired due to Fees

• Current Assignee: Artann Laboratories Inc.
• Original Assignee: Artann Laboratories Inc.
• Inventors: Sarvazyan, Armen P.
• Primary Examiner(s): Le; Long V
• Assistant Examiner(s): Bor; Helene
• Application Number:
  US12/766,383
• Publication Number:
  US 20100204643A1
• Time in Patent Office: 459 Days
• Field of Search: 600/447, 600/464, 600/461, 600/437, 604/22
• US Class Current: 600/461
• CPC Class Codes: A61B 2017/3413 guided by ultrasound
• CPC Class Codes: A61B 2090/3929 Active markers
• CPC Class Codes: A61B 5/06 Devices, other than using radiation, for detecting or locating foreign bodies for removing same A61B17/50 ; determining position of probes within or on the body of the patient
• CPC Class Codes: A61B 5/417 the bone marrow
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 8/0808 for diagnosis of the brain
• CPC Class Codes: A61B 8/0833 involving detecting or locating foreign bodies or organic structures
• CPC Class Codes: A61B 90/39 Markers, e.g. radio-opaque or breast lesions markers
• CPC Class Codes: A61M 37/0092 using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis

Abstract

An ultrasound beacon is incorporated into a needle of a drug delivery system utilizing high intensity ultrasound energy during certain cancer treatments. The beacon is configured to generate a electrical feedback signal in response to an initial ultrasound signal sent by an ultrasound transmitter. The electrical feedback signal is then sent along two electrical conductors of the needle and further over a cable back to the electronic unit. The feedback signal is then used to generate high intensity focused ultrasound using time-reversal acoustics principles. Therapeutic application of the system of the invention includes applying high intensity focused ultrasound at the site of drug delivery to enhance local tissue uptake of injected medication.

Claims

1. A method for ultrasound-assisted drug delivery, said method including the steps of:

(a) providing a dual-purpose needle with a tip equipped with a beacon, said beacon including a piezoelectric element connected to a cable via two electrical conductors,

(b) providing a time-reversal acoustic system including an electronic unit and an external ultrasound transmitter, said cable connecting said needle to said electronic unit,

(c) inserting said needle to position the tip thereof at the target tissue,

(d) injecting a drug into said tissue through said needle,

(e) generating an initial ultrasound signal by said external transmitter,

(f) receiving said initial ultrasound signal by said beacon and generating an electrical feedback signal,

(g) sending said signal along said needle via said two electrical conductors to said cable and further to said electronic unit, and

(h) focusing high intensity ultrasound at a location of said beacon by a time-reversing procedure using said electrical feedback signal.

2. The method as in claim 1, wherein said step (d) is conducted after completion of said step (g).

3. The method as in claim 1, wherein said steps (e) through (g) are repeated on a periodic basis throughout the procedure of drug delivery to refocus said high intensity acoustic energy at a location of said beacon.

4. An ultrasound-assisted drug delivery system comprising:

a dual-purpose needle having a hollow metal body and a tip equipped with a beacon formed by a piezoelectric element connected to a cable by an insulated microwire running along said needle as a first electrical conductor and by said metal body as a second electrical conductor, and

a time-reversal acoustic system including an electronic unit and an external ultrasound transmitter, said cable connecting said needle to said electronic unit,

wherein said electronic unit is configured to first cause said external transmitter to send an initial ultrasound signal, said piezoelectric element receiving said initial signal and generating an electrical feedback signal to be sent along said needle back to said electronic unit via said cable, said electronic unit further configured to focus high intensity ultrasound at a location of the beacon of said needle by a time-reversing procedure using said electrical feedback signal.

5. The system as in claim 4, further including an ultrasound image-guiding means configured for guiding said needle during insertion thereof.

6. The system as in claim 4, wherein said piezoelectric element is a strip of piezopolymer film mounted on said tip of said needle.

7. The system as in claim 4, wherein said piezoelectric element is a piezoceramic tube mounted on said tip of said needle.

8. The system as in claim 4, wherein said needle has a metal body and said piezoelectric element is connected to an insulated microwire as a first conductor and said metal body as a second conductor.

9. The system as in claim 4, wherein said external ultrasound transmitter comprises a reverberator with at least one ultrasound transducer attached thereto.

10. The system as in claim 9, wherein said external ultrasound transmitter comprises a plurality of transducers attached to said reverberator, each transducer attached to a dedicated output channel of a TRA focusing system of said electronic unit, said electronic unit further configured to conduct focusing procedure individually for each transducer and then generate high intensity focused ultrasound by activating all transducers at the same time.

15. The system as in claim 10, wherein said stylet protrudes through said tip of said needle such that said piezoelectric element is spaced out from the tip of said needle by a distance equal to about one wavelength of said ultrasound.

11. An ultrasound-assisted drug delivery system comprising:

a dual-purpose needle having a hollow non-conductive body and a tip equipped with a beacon including a piezoelectric element connected to a cable by two electrical conductors imbedded into said non-conductive body of said needle, and

a time-reversal acoustic system including an electronic unit and an external ultrasound transmitter, said cable connecting said needle to said electronic unit,

wherein said electronic unit is configured to first cause said external transmitter to send an initial ultrasound signal, said piezoelectric element configured to generate an electrical feedback signal in response to said initial signal and to send said electrical feedback signal along said needle back to said electronic unit via said cable, said electronic unit further configured to focus high intensity ultrasound at a location of the beacon of said needle with a time-reversing procedure using said electrical feedback signal.

12. The system as in claim 11, wherein said needle is made from a hard non-conductive polymer material.

13. The system as in claim 11, wherein said needle is made from a soft non-conductive material, said needle further including a rigid removable stylet adapted to make said needle rigid during insertion.

14. An ultrasound-assisted drug delivery system comprising:

a dual-purpose needle having a removable stylet equipped with a beacon at a tip thereof, said beacon including a piezoelectric element connected to a cable by two electrical conductors contained within said stylet, said cable connecting said stylet to said electronic unit, and

a time-reversal acoustic system including an electronic unit and an external ultrasound transmitter,

wherein said electronic unit is configured to first cause said external transmitter to send an initial ultrasound signal, said piezoelectric element configured to generate an electrical feedback signal in response thereto and send it along said needle back to said electronic unit via said cable, said electronic unit further configured to focus high intensity acoustic energy at a location of the beacon of said stylet with a time-reversing procedure using said electrical feedback signal.